Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia

Cellular Oncology

Volumn 30, Issue 4, 2008, Pages 299-306

  Hess, C J ^a   Ameziane, N ^a   Schuurhuis, G J ^a   Errami, A ^b   Denkers, F ^a   Kaspers, G J L ^a,d   Cloos, J ^a   Joenje, H ^a   Reinhardt, D ^c   Ossenkoppele, G J ^a   Zwaan, C M ^d,e   Waisfisz, Q ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MRC HOLLAND   (Netherlands)

^c AML BFM Study Group   (Germany)

^d DUTCH CHILDHOOD ONCOLOGY GROUP   (Netherlands)

^e SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Fanconi anaemia; Methylation; MS MLPA; Sporadic acute leukaemia

Indexed keywords

BISULFITE; GENOMIC DNA; MITOMYCIN C;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW EXAMINATION; CANCER RISK; CANCER SUSCEPTIBILITY; CHEMOSENSITIVITY; CHILD; CHROMOSOMAL INSTABILITY; COLONY FORMING UNIT; CONCENTRATION RESPONSE; DNA METHYLATION; DNA REPAIR; FANCONI ANEMIA; GENE AMPLIFICATION; HUMAN; HUMAN CELL; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; METHYLATION SPECIFIC MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SPORADIC ACUTE LEUKEMIA;

ADULT; BONE MARROW CELLS; CHILD; CHILD, PRESCHOOL; CROSS-LINKING REAGENTS; DNA METHYLATION; DNA MODIFICATION METHYLASES; FANCONI ANEMIA COMPLEMENTATION GROUP C PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP L PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MITOMYCIN; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROMOTER REGIONS (GENETICS); TUMOR STEM CELL ASSAY;

EID: 47749098040     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: 10.3233/CLO-2008-0426     Document Type: Article

References (22)

1. M. Levitus, H. Joenje and J.P. de Winter, The Fanconi anemia pathway of genomic maintenance, Cell. Oncol. 28(1/2) (2006), 3-29.
2. L.J. Niedernhofer, A.S. Lalai and J.H. Hoeijmakers, Fanconi anemia (cross)linked to DNA repair, Cell 123(7) (2005), 1191-1198.
3. A. Lyakhovich and J. Surralles, Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer, Cancer Lett. 232(1) (2006), 99-106.
4. T. Taniguchi and A.D. D'Andrea, Molecular pathogenesis of Fanconi anemia: recent progress, Blood 107(11) (2006), 4223-4233.
5. O.I. Olopade and M. Wei, FANCF methylation contributes to chemoselectivity in ovarian cancer, Cancer Cell 3(5) (2003), 417-420.
6. G. Narayan, H. Arias-Pulido, S.V. Nandula, K. Basso, D.D. Sugirtharaj, H. Vargas, M. Mansukhani, J. Villella, L. Meyer, A. Schneider, L. Gissmann, M. Durst, B. Pothuri and V.V. Murty, Promoter hypermethylation of FANCF: disruption of Fanconi anemia-BRCA pathway in cervical cancer, Cancer Res. 64(9) (2004), 2994-2997.
7. C.J. Marsit, M. Liu, H.H. Nelson, M. Posner, M. Suzuki and K.T. Kelsey, Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival, Oncogene 23(4) (2004), 1000-1004.
8. A. Condie, R.L. Powles, C.D. Hudson, V. Shepherd, S. Bevan, M.R. Yuille and R.S. Houlston, Analysis of the Fanconi anaemia complementation group A gene in acute myeloid leukaemia, Leuk. Lymph. 43(9) (2002), 1849-1853.
9. M. Tischkowitz, N. Ameziane, Q. Waisfisz, J.P. de Winter, R. Harris, T. Taniguchi, A. D'Andrea, S.V. Hodgson, C.G. Mathew and H. Joenje, Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia, Br. J. Haematol. 123(3) (2003), 469-471.
10. M.W. Lensch, M. Tischkowitz, T.A. Christianson, C.A. Reifsteck, S.A. Speckhart, P.M. Jakobs, M.E. O'Dwyer, S.B. Olson, M.M. Le Beau, S.V. Hodgson, C.G. Mathew, R.A. Larson and G.C. Bagby, Jr., Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia, Blood 102(1) (2003), 7-16.
11. M.D. Tischkowitz, N.V. Morgan, D. Grimwade, C. Eddy, S. Ball, I. Vorechovsky, S. Langabeer, R. Stoger, S.V. Hodgson and C.G. Mathew, Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia, Leukemia 18(3) (2004), 420-425.
12. S. Meyer, D.J. White, A.M. Will, T. Eden, A. Sim, R. Brown and G. Strathdee, No evidence of significant silencing of Fanconi genes FANCF and FANCB or Nijmegen breakage syndrome gene NBS1 by DNA hyper-methylation in sporadic childhood leukaemia, Br. J. Haematol. 134(1) (2006), 61-63.
13. A.O. Nygren, N. Ameziane, H.M. Duarte, R.N. Vijzelaar, Q. Waisfisz, C.J. Hess, J.P. Schouten and A. Errami, Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences, Nucleic Acids Res. 33(14) (2005), e128.
14. D.I. Kutler, B. Singh, J. Satagopan, S.D. Batish, M. Berwick, P.F. Giampietro, H. Hanenberg and A.D. Auerbach, A 20-year perspective on the International Fanconi Anemia Registry (IFAR), Blood 101(4) (2003), 1249-1256.
15. M. Tischkowitz and I. Dokal, Fanconi anaemia and leukaemia - clinical and molecular aspects, Br. J. Haematol. 126(2) (2004), 176-191.
16. B.P. Alter, P.S. Rosenberg and L.C. Brody, Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2, J. Med. Genet. 44(1) (2007), 1-9.
17. T. Taniguchi, M. Tischkowitz, N. Ameziane, S.V. Hodgson, C.G. Mathew, H. Joenje, S.C. Mok and A.D. D'Andrea, Disruption of the Fanconi anemia-BRCA pathway in cisplatinsensitive ovarian tumors, Nat. Med. 9(5) (2003), 568-574.
18. S. Reid, D. Schindler, H. Hanenberg, K. Barker, S. Hanks, R. Kalb, K. Neveling, P. Kelly, S. Seal, M. Freund, M. Wurm, S.D. Batish, F.P. Lach, S. Yetgin, H. Neitzel, H. Ariffin, M. Tischkowitz, C.G. Mathew, A.D. Auerbach and N. Rahman, Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer, Nat. Genet. 39(2) (2007), 162-164.
19. B. Xia, J.C. Dorsman, N. Ameziane, Y. de Vries, M.A. Rooimans, Q. Sheng, G. Pals, A. Errami, E. Gluckman, J. Llera, W. Wang, D.M. Livingston, H. Joenje and J.P. de Winter, Fanconi anemia is associated with a defect in the BRCA2 partner PALB2, Nat. Genet. 39(2) (2007), 159-161.
20. J.C. Dorsman, M. Levitus, D. Rockx, M.A. Rooimans, A.B. Oostra, A. Haitjema, S.T. Bakker, J. Steltenpool, D. Schuler, S. Mohan, D. Schindler, F. Arwert, G. Pals, C.G. Mathew, Q.Waisfisz, J.P. deWinter and H. Joenje, Identification of the Fanconi anemia complementation group I gene, FANCI, Cell. Oncol. 29(3) (2007), 211-218.
21. A.E. Sims, E. Spiteri, R.J. Sims, 3rd, A.G. Arita, F.P. Lach, T. Landers, M. Wurm, M. Freund, K. Neveling, H. Hanenberg, A.D. Auerbach and T.T. Huang, FANCI is a second monoubiquitinated member of the Fanconi anemia pathway, Nat. Struct. Mol. Biol. 14(6) (2007), 564-567.
22. A. Smogorzewska, S. Matsuoka, P. Vinciguerra, E.R. McDonald, 3rd, K.E. Hurov, J. Luo, B.A. Ballif, S.P. Gygi, K. Hofmann, A.D. D'Andrea and S.J. Elledge, Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair, Cell 129(2) (2007), 289-301.